BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Virchows Archiv

• Publication date

  2012-07-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-012-1286-zPMID 22820987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype

  2012cited by this paper
• Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.

  2012cited by this paper
• Proteomics of Mouse BRCA1-deficient Mammary Tumors Identifies DNA Repair Proteins with Potential Diagnostic and Prognostic Value in Human Breast Cancer*

  2012cited by this paper
• Molecular insights on basal-like breast cancer

  2012cited by this paper
• Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese

  2012cited by this paper
• Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population

  2011cited by this paper
• Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis.

  2011cited by this paper
• Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy.

  2011cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cited by this paper
• Therapeutic options for triple-negative breast cancers with defective homologous recombination.

  2009cited by this paper
• Expression of BRCA1 protein in breast cancer and its prognostic significance.

  2008cited by this paper
• Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.

  2008cited by this paper
• Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.

  2007cited by this paper
• Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families

  2006cited by this paper
• Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

  2006cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

  2006cited by this paper
• Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

  2004cited by this paper
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Expression of luminal and basal cytokeratins in human breast carcinoma

  2004cited by this paper
• Prognostic significance of BRCA1 expression in sporadic breast carcinomas

  2003cited by this paper
• Placebo effects in oncology.

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Behavioural genetics: Worms gang up on bacteria

  2002cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• Sporadic breast cancer in young women: Prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2

  2002cited by this paper
• BRCA1 methylation: a significant role in tumour development?

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non‐familial breast cancers

  1998cited by this paper
• BRCA2 mutations in primary breast and ovarian cancers

  1996cited by this paper
• The genetic attributable risk of breast and ovarian cancer

  1996cited by this paper
• Distinct transcription start sites generate two forms of BRCA1 mRNA.

  1995cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper

• The Relationship Between BRCA1 Expression and Grade in Breast Cancer Patients in NTB

  2025cites this paper
• BRCA1 promoter methylation & its immunohistochemical correlation in sporadic breast cancer

  2023cites this paper
• Methylation of BRCA1 promoter in sporadic breast cancer

  2023cites this paper
• RNA Interference Induces BRCA1 Gene Methylation and Increases the Radiosensitivity of Breast Cancer Cells

  2022cites this paper
• Co-Relation of Hormonal Profile and BRCA1 in Sporadic Breast Carcinoma: A Single Institutional Experience of 303 Patients

  2022cites this paper
• The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis

  2021cites this paper
• Immunohistochemical expression of ER, PR, HER2, Ki67, CK5/6 and BRCA1 in non familial breast cancer and its correlation with clinico-pathological parameters

  2021cites this paper
• BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer

  2020cites this paper
• MethHC 2.0: information repository of DNA methylation and gene expression in human cancer

  2020cites this paper
• Glucose Concentration in Cell Culture Medium Influences the BRCA1-Mediated Regulation of the Lipogenic Action of IGF-I in Breast Cancer Cells

  2020cites this paper
• The Correlation of BRCA 1 Promoter Methylation and Clinicopathological Appearance in Breast Cancer

  2018influential citation
• Association of BRCA1 Promoter Methylation with Breast Cancer in Asia: A Meta- Analysis

  2018cites this paper
• The role of plant-based nutrition in cancer prevention

  2018cites this paper
• PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer

  2018cites this paper
• A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?

  2018cites this paper
• Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

  2018cites this paper
• BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

  2017cites this paper
• BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA‐like breast cancers treated with neoadjuvant chemotherapy

  2017cites this paper
• The role of BRCA status on prognosis in patients with triple-negative breast cancer

  2017cites this paper
• DNA methylation of candidate genes in peripheral blood from patients with type 2 diabetes or the metabolic syndrome

  2017cites this paper
• Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities.

  2017cites this paper
• Estudio mutacional de EGFR y PIK3CA y de hipermetilación del promotor del gen BRCA1 en cáncer de mama tipo «triple negativo»

  2017cites this paper
• Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients

  2016influential citation
• DNA Methylation in Breast Cancer

  2016cites this paper
• Epigenetic Control of Genes Involved in Cancer Initiation and Progression

  2016cites this paper
• Role of BRCA1 in Breast Cancer Metastasis

  2016cites this paper
• Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and “BRCA-Like” Status, in Both Blood and Tumour DNA

  2016cites this paper
• Critical role for BRCA1 expression as a marker of chemosensitivity response and prognosis.

  2016cites this paper
• Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients.

  2015cites this paper
• Implications of BRCA1 mutations in basal-like breast cancer development and treatment

  2015cites this paper
• Molecular Medicine and Personalized Therapy for Breast Cancer Patients

  2015cites this paper
• Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer

  2015cites this paper
• Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies

  2015cites this paper
• Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis

  2015cites this paper
• Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

  2014cites this paper
• BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer

  2014cites this paper
• Epigenetics of BRCA-1–Related Breast Tumorigenesis and Dietary Prevention

  2014cites this paper
• THE ROLE OF GERMLINE BRCA1 FOUNDER MUTATIONS AND SOMATIC TP53 MUTATIONS IN THE TRIPLE-NEGATIVE BREAST CANCER SUBTYPE

  2014cites this paper
• SIGNIFICANCE OF ERα , HER 2 , AND CAV 1 EXPRESSION AND MOLECULAR SUBTYPE CLASSIFICATION TO CANINE MAMMARY GLAND TUMOR Submitted

  2013cites this paper
• Do age-related changes in DNA methylation play a role in the development of age-related diseases?

  2013cites this paper
• BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer

  2013cites this paper
• Chromatin organisation in breast cancer

  2013cites this paper
• Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer

  2013cites this paper
• The role of age-related DNA methylation in the development of age-related disease

  2013cites this paper
• Targeting the HER2 receptor in metastatic breast cancer.

  2012cites this paper